Larry Biegelsen
Stock Analyst at Wells Fargo
(2)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HYPR Hyperfine | Maintains: Equal-Weight | 1 1 | 1.28 | -33.59% | 6 | Aug 15, 2025 | |
TNDM Tandem Diabetes Care | Maintains: Equal-Weight | 20 13 | 10.11 | 28.59% | 10 | Aug 7, 2025 | |
EW Edwards Lifesciences | Maintains: Overweight | 84 88 | 78.21 | 12.52% | 17 | Aug 7, 2025 | |
ALC Alcon | Reinstates: Equal-Weight | 93 | 84.68 | 9.83% | 9 | Aug 6, 2025 | |
INSP Inspire Medical Syst... | Maintains: Equal-Weight | 174 101 | 79.67 | 26.77% | 13 | Aug 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 435 445 | 376.68 | 18.14% | 15 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 137 131 | 115.98 | 12.95% | 6 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 3 | 1.54 | 94.81% | 7 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 33 24 | 23.47 | 2.26% | 17 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 86 92 | 86.99 | 5.76% | 15 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 15 | 13.65 | 9.89% | 7 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 108 100 | 84.05 | 18.98% | 11 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 315 290 | 239.88 | 20.89% | 19 | Jul 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 40 15 | 10.91 | 32.91% | 18 | Jul 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 118 124 | 102.78 | 20.65% | 13 | Jul 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 559 599 | 471.96 | 26.92% | 20 | Jul 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 27 | 14.66 | 84.17% | 2 | Jul 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 9 | 6.64 | 35.54% | 14 | Jul 9, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 118 93 | 70.89 | 31.19% | 17 | May 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 113 98 | 100.02 | -2.02% | 10 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 89 | 73.02 | 21.88% | 4 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 8.86 | 91.87% | 1 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 166 152 | 173.87 | -12.58% | 13 | Jan 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 65 80 | 79.97 | 0.04% | 6 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 94 | 77.88 | 20.7% | 9 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 106 98 | 92.75 | 5.66% | 17 | Nov 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 14 | 5.84 | 139.73% | 11 | Apr 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 200 210 | 334.75 | -37.27% | 6 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 68 71 | n/a | n/a | 6 | Jan 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 40 49 | 12.75 | 284.31% | 2 | Dec 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 136 | 131.33 | 3.56% | 21 | Apr 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 59.45 | 17.75% | 7 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 62 | 39.75 | 55.97% | 6 | May 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 270 | 192.59 | 40.19% | 5 | Apr 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 2, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Apr 25, 2017 |